1Back SA,Han BH,Luo NL,et al.Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia.J Neurosci,2002,22:455-463.
2Back SA,Luo NL,Borenstein NS,et al.Late oligodendroeyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury.J Neurosci,2001,21:1302-1312.
3Inder T,Mocatta T,Darlow B,et al.Elevated free radical products in the eerebrospinal fluid of VLBW infants with cerebral white matter injury.Pediatr Res,2002,52:213-218.
4Back SA,Luo NL,Mallinson RA,et al.Selective vulnerability of Preterm white matter to oxidative damage defined by F2-isoprostanes.Ann Neurol,2005,58:108-120.
5Folkerth RD,Haynes RL,Borenstein NS,et al.Developmental lag in superoxide dismutases relative to other antioxidant enzymes in premyelinated human teleneephalic white matter.J Neuropathol Exp Neurol,2004,63:990-999.
6Baud O,Li J,Zhang Y,et al.Nitric oxide-induced cell death in developing oligodendrocytes is associated with mitochodrial dysfunction and apoptosis-inducing factor translocation.Eur J Neurosci,2004,20:1713-1726.
7Folkerth RD,Keefe RJ,Haynes RL,et al.Interferon-gamma expression in periventricular leukomalacia in the human brain.Brain Pathol,2004,14:265-274.
8Brault S,Martinez-Bermudez AK,Roberts J 2nd,et al.Cytotoxicity of the E-(2)-isoprostane 15-E-(2t)-IsoP on oligodendrocyte progenitors.Free Radic Biol Med,2004,37:358-366.
9Karadottir R,Cavelier P,Bergersen LH,et al.NMDA receptors are expressed in oligodendrocytes and activated in ischaemia.Nature,2005,438:1162-1166.
10Follett PL,Deng W,Dai W,et al.Glutamate receptor mediated oligodendrocyte toxicity in periventricular leukomalacia:a protective role for topiramate.J Neurosci,2004,24:4412-4420.
